Study on the Rule and Mechanism of Treating Functional Gastrointestinal Diseases From the Perspective of Liver and Spleen
Status:
Recruiting
Trial end date:
2022-03-30
Target enrollment:
Participant gender:
Summary
To clarify the changes of intestinal flora - gut - brain axis in FGIDs patients represented
by NERD disharmony of liver and stomach and IBS-D disharmony of liver and spleen, and confirm
that the imbalance between intestinal flora and host co-metabolism is the key to the
pathogenesis of functional gastrointestinal disease. To reveal the common mechanism of
regulating liver and spleen (stomach) in treating FGIDs dynamic disorder and visceral
hypersensitivity by regulating intestinal flora - intestine - brain axis disorder.
Phase:
Phase 4
Details
Lead Sponsor:
Xiyuan Hospital of China Academy of Chinese Medical Sciences